Home » High-Quality Health Information » Health Topics » Uterine Cancer » Study: NCT01005329

| Print this page

• Home
• High-Quality
  Health Information
  • Health Topics
  • Health Resources
• Understanding Health Research
  • What is health research?
  • Is health research safe?
  • Is health research
    right for me?
• Health Research in Massachusetts
  • Search Ongoing Studies
  • Community-Engaged Research Projects
  • Community Health Centers

Title:	Intensity-Modulated Radiation Therapy, Cisplatin, and Bevacizumab Followed by Carboplatin and Paclitaxel in Treating Patients Who Have Undergone Surgery for Endometrial Cancer
Status:	Recruiting participants
Conditions:	Endometrial Cancer
Interventions:	Biological: bevacizumab; Drug: carboplatin; Drug: cisplatin; Drug: paclitaxel; Procedure: adjuvant therapy; Radiation: intensity-modulated radiation therapy
Institutions:	Brigham and Women's Hospital, Dana-Farber Cancer Institute
Health Topics:	Uterine Cancer
View this study on ClinicalTrials.gov

Contact Information

---

© Community Connect to Research, 2012